A study that offered a mechanistic correlation to severe disease showed that the expression levels of placental ACE2 (but not TMPRSS2 or Furin) and the protein levels of IFITM1 and IFITM3 were higher in women with severe COVID-19 (Mourad et al., 2021). The gene discussed is ACE2; the disease is COVID-19.